Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments-Reference-Cited by-同舟云学术

Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments

Published:2016-03-21 Issue:3 Volume:11 Page:e0152132
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wei Chuanqi,Ni Wentao,Cai Xuejiu,Zhao Jin,Cui Junchang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Stenotrophomonas maltophilia: an emerging opportunist human pathogen;W Looney;Lancet Infect Dis,2009

2. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009–2012;HS Sader;Int J Antimicrob Agents,2014

3. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen;Brooke Joanna S.;Clin. Microbiol. Rev,2012

4. Management of Adverse Reactions to Trimethoprim-Sulfamethoxazole in Human Immunodeficiency Virus-Infected Patients;C Alan;Arch Intern Med,1994

5. Microbiological and clinical aspects of infection caused by Stenotrophomonas maltophilia;M Denton;Clin Microbiol Rev,1998

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice;Current Opinion in Infectious Diseases;2024-07-30

2. Stenotrophomonas maltophilia: The Landscape in Critically Ill Patients and Optimising Management Approaches;Antibiotics;2024-06-22

3. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach;Antibiotics;2024-06-13

4. Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study;Expert Review of Anti-infective Therapy;2024-05-13

5. Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies;Journal of Clinical Medicine;2024-04-14